Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Hendrickson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nature Genetics|March 30, 2016
Tet proteins enhance the developmental hourglassPeter G Hendrickson, Bradley R Cairns
Mycologia|October 15, 2010
RNA editing is absent in a single mitochondrial gene of Didymium iridisPeter G Hendrickson, Margaret E Silliker
Current Genetics|February 20, 2010
RNA editing in six mitochondrial ribosomal protein genes of Didymium iridisPeter G Hendrickson, Margaret E Silliker
Oncoimmunology|February 1, 2020
The promise of adoptive cellular immunotherapies in hepatocellular carcinomaPeter G Hendrickson, Michael Olson, Tim Luetkens, et al.
Advances in Radiation Oncology|January 15, 2025
Response to Central Boost Radiation Therapy in Unresectable Retroperitoneal Sarcoma: A Case SeriesDanielle N Burner, Peter G Hendrickson, Diana M Cardona, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Efficacy of Minnelide in a Next-Generation Dual-Recombinase Regulated Genetically Engineered Mouse Model of CIC::DUX4 SarcomaMaKenna R Browne, Axel V Silver, Risha Banerjee, et al.
Research Square|November 14, 2023
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse modelsPeter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse modelsPeter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, et al.
Oncogene|September 23, 2023
Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastomaKevin J Tu, Connor E Stewart, Peter G Hendrickson, et al.
The Journal of Clinical Investigation|June 16, 2026
Targeting CIC::DUX4 sarcoma with Minnelide in a dual recombinase-initiated genetically engineered mouse modelMaKenna R Browne, Axel V Silver, Risha Banerjee, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature Genetics|March 30, 2016
Tet proteins enhance the developmental hourglassPeter G Hendrickson, Bradley R Cairns
Mycologia|October 15, 2010
RNA editing is absent in a single mitochondrial gene of Didymium iridisPeter G Hendrickson, Margaret E Silliker
Current Genetics|February 20, 2010
RNA editing in six mitochondrial ribosomal protein genes of Didymium iridisPeter G Hendrickson, Margaret E Silliker
Oncoimmunology|February 1, 2020
The promise of adoptive cellular immunotherapies in hepatocellular carcinomaPeter G Hendrickson, Michael Olson, Tim Luetkens, et al.
Advances in Radiation Oncology|January 15, 2025
Response to Central Boost Radiation Therapy in Unresectable Retroperitoneal Sarcoma: A Case SeriesDanielle N Burner, Peter G Hendrickson, Diana M Cardona, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Efficacy of Minnelide in a Next-Generation Dual-Recombinase Regulated Genetically Engineered Mouse Model of CIC::DUX4 SarcomaMaKenna R Browne, Axel V Silver, Risha Banerjee, et al.
Research Square|November 14, 2023
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse modelsPeter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse modelsPeter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, et al.
Oncogene|September 23, 2023
Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastomaKevin J Tu, Connor E Stewart, Peter G Hendrickson, et al.
The Journal of Clinical Investigation|June 16, 2026
Targeting CIC::DUX4 sarcoma with Minnelide in a dual recombinase-initiated genetically engineered mouse modelMaKenna R Browne, Axel V Silver, Risha Banerjee, et al.
Pageof 2